U.S. approves GSK's purchase of Novartis vaccine business-companies

WASHINGTON, Nov 26 (Reuters) - GlaxoSmithKline won U.S. antitrust approval to buy Novartis AG's vaccine business, with the exception of influenza vaccines, the two companies said on Wednesday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.